Julie Vincent
Dijon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
18F-FDG and 18F-Fluorocholine PET as Prognostic Biomarkers in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Prospective Multicenter Study.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: September 29, 2025
FOLFIRINOX-3 plus bevacizumab (bFOLFIRINOX3) in chemo-refractory metastatic colorectal cancer: a multicenter phase II trial.
Journal: Future oncology (London, England)
Published: February 06, 2025
Factors Influencing the Duration of Maintenance Therapy in Metastatic Colorectal Cancer.
Journal: Cancers
Published: October 17, 2024
Safety and efficacy of trifluridine/tipiracil +/- bevacizumab plus XB2001 (anti-IL-1α antibody): a single-center phase 1 trial.
Journal: Signal transduction and targeted therapy
Published: September 02, 2024
Plasma clearance of 5-fluorouracil is more influenced by variations in glomerular filtration rate than by uracil concentration.
Journal: Cancer chemotherapy and pharmacology
Published: July 25, 2024
Effect of radiochemotherapy on peripheral immune response in glioblastoma.
Journal: Cancer immunology, immunotherapy : CII
Published: March 29, 2024
FOLFIRI-bevacizumab as a second-line treatment for advanced biliary tract cancer after gemcitabine-based chemotherapy.
Journal: Frontiers in oncology
Published: September 13, 2023
Performance of a blood-based RNA signature for gemcitabine-based treatment in metastatic pancreatic adenocarcinoma.
Journal: Journal of gastrointestinal oncology
Published: September 28, 2022
Efficacy of Chemotherapy Plus Bevacizumab in Recurrent Glioblastoma Multiform: A Real-life Study.
Journal: Anticancer research
Published: September 25, 2022
Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 16, 2021
Seroprevalence of SARS-CoV-2 among the staff and patients of a French cancer centre after first lockdown: The canSEROcov study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 12, 2021
Last Updated: 09/26/2026